Authors:
Nurmi, E
Ruottinen, HM
Kaasinen, V
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
Citation: E. Nurmi et al., Progression in Parkinson's disease: A positron emission tomography study with a dopamine transporter ligand [F-18] CFT, ANN NEUROL, 47(6), 2000, pp. 804-808
Authors:
Laihinen, A
Ruottinen, H
Rinne, JO
Haaparanta, M
Bergman, J
Solin, O
Koskenvuo, M
Marttila, R
Rinne, UK
Citation: A. Laihinen et al., Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [F-18]6-fluorodopa PET, J NEUROL, 247, 2000, pp. 110-113
Authors:
Nurmi, E
Bergman, J
Eskola, O
Solin, O
Hinkka, SM
Sonninen, P
Rinne, JO
Citation: E. Nurmi et al., Reproducibility and effect of levodopa on dopamine transporter function measurements: A [F-18]CFT PET study, J CEREBR B, 20(11), 2000, pp. 1604-1609
Authors:
Bergman, J
Janosik, T
Yudina, L
Desarbre, E
Lidgren, G
Venemalm, L
Citation: J. Bergman et al., Reactions of 1,2-bis(1H-indol-2-yl)ethane: Formation of indolo[2,3-c]carbazole and cyclohept[1,2-b : 5,4-b ']bisindole derivatives, TETRAHEDRON, 56(13), 2000, pp. 1911-1916
Authors:
Ruottinen, HM
Partinen, M
Hublin, C
Bergman, J
Haaparanta, M
Solin, O
Rinne, JO
Citation: Hm. Ruottinen et al., An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome, NEUROLOGY, 54(2), 2000, pp. 502-504
Authors:
Yang, Y
Griffiths, WJ
Nordling, M
Nygren, J
Moller, L
Bergman, J
Liepinsh, E
Otting, G
Gustafsson, JA
Rafter, J
Sjovall, J
Citation: Y. Yang et al., Ring opening of benzo[a]pyrene in the germ-free rat is a novel pathway forformation of potentially genotoxic metabolites, BIOCHEM, 39(50), 2000, pp. 15585-15591
Authors:
Rinne, JO
Portin, R
Ruottinen, H
Nurmi, E
Bergman, J
Haaparanta, M
Solin, O
Citation: Jo. Rinne et al., Cognitive impairment and the brain dopaminergic system in Parkinson disease - [F-18]fluorodopa positron emission tomographic study, ARCH NEUROL, 57(4), 2000, pp. 470-475
Authors:
Laakso, A
Vilkman, H
Alakare, B
Haaparanta, M
Bergman, J
Solin, O
Peurasaari, J
Rakkolainen, V
Syvalahti, E
Hietala, J
Citation: A. Laakso et al., Striatal dopamine transporter binding in neuroleptic-naive patients with schizophrenia studied with positron emission tomography, AM J PSYCHI, 157(2), 2000, pp. 269-271
Authors:
Laakso, A
Vilkman, H
Kajander, J
Bergman, J
Haaparanta, M
Solin, O
Hietala, J
Citation: A. Laakso et al., Prediction of detached personality in healthy subjects by low dopamine transporter binding, AM J PSYCHI, 157(2), 2000, pp. 290-292
Authors:
Srinivasan, PT
Viraraghavan, T
Bergman, J
Citation: Pt. Srinivasan et al., Factors influencing residual aluminium levels at the Buffalo Pound Water Treatment Plant, Saskatchewan, Canada, J WAT SER T, 48(4), 1999, pp. 167-175
Authors:
Kahkonen, M
Harila-Saari, A
Metsahonkala, L
Korhonen, T
Norvasuo-Heila, MK
Utriainen, T
Ahonen, A
Bergman, J
Salmi, TT
Minn, H
Citation: M. Kahkonen et al., Cerebral blood flow and glucose metabolism in long-term survivors of childhood acute lymphoblastic leukaemia, EUR J CANC, 35(7), 1999, pp. 1102-1108
Authors:
Hietala, J
Syvalahti, E
Vilkman, H
Vuorio, K
Rakkolainen, V
Bergman, J
Haaparanta, M
Solin, O
Kuoppamaki, M
Eronen, E
Ruotsalainen, U
Salokangas, RKR
Citation: J. Hietala et al., Depressive symptoms and presynaptic dopamine function in neuroleptic-naiveschizophrenia, SCHIZOPHR R, 35(1), 1999, pp. 41-50
Authors:
Rinne, JO
Bergman, J
Ruottinen, H
Haaparanta, M
Eronen, E
Oikonen, V
Sonninen, P
Solin, O
Citation: Jo. Rinne et al., Striatal uptake of a novel PET ligand, [F-18]beta-CFT, is reduced in earlyParkinson's disease, SYNAPSE, 31(2), 1999, pp. 119-124
Authors:
Harbecke, O
Dahlgren, C
Bergman, J
Moller, L
Citation: O. Harbecke et al., The synthetic non-toxic drug 2,3-dimethyl-6(2-dimethylaminoethyl)-6H-indolo-(2,3-b)quinoxaline inhibits neutrophil production of reactive oxygen species, J LEUK BIOL, 65(6), 1999, pp. 771-777
Citation: J. Tholander et J. Bergman, Probing the TCDD receptor: Synthesis of 5,6-dihydro-6a,11,11b-triazabenzo[a]fluorene center dot PF6, a potential ligand, HETEROCYCLE, 51(6), 1999, pp. 1275
Authors:
Takala, TO
Nuutila, P
Katoh, C
Luotolahti, M
Bergman, J
Maki, M
Oikonen, V
Ruotsalainen, U
Gronroos, T
Haaparanta, M
Kapanen, S
Knuuti, J
Citation: To. Takala et al., Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulation, AM J P-ENDO, 277(4), 1999, pp. E585-E590